BIOMARKER:

EGFR exon 19 deletion + EGFR G724S

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Lung Cancer Lung Cancer	EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Lung Cancer Lung Cancer	dacomitinib Sensitive: C4 – Case Studies Invest New Drugs - 4 weeks (New C4)	dacomitinib Sensitive: C4 – Case Studies Invest New Drugs - 4 weeks - (New C4)
EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Non Small Cell Lung Cancer NSCLC	EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: C3 – Early Trials	afatinib Sensitive: C3 – Early Trials
EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Non Small Cell Lung Cancer NSCLC	EGFR exon 19 deletion + EGFR G724S EGFR exon 19 deletion + EGFR G724S	Non Small Cell Lung Cancer NSCLC	dacomitinib Resistant: C3 – Early Trials	dacomitinib Resistant: C3 – Early Trials